Clinical Trial Update: The Efficacy and Safety of rhTNK-tPA in Comparison With Alteplase(Rt-PA) as Fibrinolytic Therapy of Acute STEMI [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rhTNK-tPA with alteplase for fibrinolytic therapy in acute STEMI (trial completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St Elevation Myocardial Infarction

Drugs mentioned

• alteplase (rt-PA) (alteplase)
• rhTNK-tPA (tenecteplase)

Snippet

Sponsor: CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. | Conditions: Acute ST Elevation Myocardial Infarction | Phase 4 | Status: COMPLETED